Journal
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 74, Issue 5, Pages 478-U33Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/0250-474X.108441
Keywords
Biopharmaceutic classification system; drug permeability; lamivudine; single pass intestinal perfusion
Categories
Ask authors/readers for more resources
The intestinal transport of lamivudine, a nucleotide reverse transcriptase inhibitor, was investigated using the single pass intestinal perfusion technique in male Wistar rats. Single pass intestinal perfusion was performed in small intestine at a flow rate of 0.20 ml/min. Lamivudine exhibits a high intestinal permeability over the length of the small intestine indicative of compounds that are well absorbed. The Peff of lamivudine is in the range of drugs with high intestinal permeability and high fraction of dose absorbed indicating that lamivudine readily crosses the intestine. This also suggests that lamivudine belongs to biopharmaceutics classification system class I and is a good candidate for biopharmaceutics classification system based biowaiver. The permeability values obtained from this study may be useful in models of exposure assessment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available